肿瘤指南

订阅

MedSci主页 / 所有栏目 / 肿瘤指南

2021 欧洲专家共识：一线BRCA/同源重组缺陷检测

2021-11-30 国外肿瘤科相关专家小组（统称） Ann Oncol

卵巢癌妇科肿瘤BRCA基因检测同源重组缺陷检测

HRR缺陷的卵巢癌通常对于PARP抑制剂敏感，本文推荐了一系列基因检测的方法，以确定卵巢癌对于PARP抑制剂敏感性的预测因子，并确定遗传易感性。

中文标题：

2021 欧洲专家共识：一线BRCA/同源重组缺陷检测

英文标题：

European Experts Consensus: BRCA/Homologous Recombination Deficiency Testing in First-Line Ovarian Cancer

发布机构：

国外肿瘤科相关专家小组（统称）

发布日期：

2021-11-30

简要介绍：

同源重组修复（HRR）可实现双链DNA断裂的无故障修复，约有一半的高级别浆液性卵巢癌患者中存在HRR缺陷。HRR缺陷的卵巢癌通常对于PARP抑制剂敏感，本文推荐了一系列基因检测的方法，以确定卵巢癌对于PARP抑制剂敏感性的预测因子，并确定遗传易感性。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 欧洲专家共识：一线卵巢癌BRCA_同源重组缺陷检测.pdf)] GetToolGuiderByIdResponse(projectId=1, id=2d33a1c00228a938, title=2021 欧洲专家共识：一线BRCA/同源重组缺陷检测, enTitle=European Experts Consensus: BRCA/Homologous Recombination Deficiency Testing in First-Line Ovarian Cancer, guiderFrom=Ann Oncol, authorId=0, author=, summary=HRR缺陷的卵巢癌通常对于PARP抑制剂敏感，本文推荐了一系列基因检测的方法，以确定卵巢癌对于PARP抑制剂敏感性的预测因子，并确定遗传易感性。, cover=https://img.medsci.cn/2021126/1638799053381_1608702.png, journalId=0, articlesId=null, associationId=887, associationName=国外肿瘤科相关专家小组（统称）, associationIntro=null, copyright=0, guiderPublishedTime=Tue Nov 30 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">同源重组修复（HRR）可实现双链DNA断裂的无故障修复，约有一半的高级别浆液性卵巢癌患者中存在HRR缺陷。HRR缺陷的卵巢癌通常对于PARP抑制剂敏感，本文推荐了一系列基因检测的方法，以确定卵巢癌对于PARP抑制剂敏感性的预测因子，并确定遗传易感性。</span></p>, tagList=[TagDto(tagId=359, tagName=卵巢癌), TagDto(tagId=1983, tagName=妇科肿瘤), TagDto(tagId=21027, tagName=BRCA基因检测), TagDto(tagId=119150, tagName=同源重组缺陷检测)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=115339, guiderKeyword=同源重组修复缺陷, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2341, appHits=29, showAppHits=0, pcHits=402, showPcHits=2312, likes=0, shares=5, comments=8, approvalStatus=1, publishedTime=Mon Dec 06 22:10:05 CST 2021, publishedTimeString=2021-11-30, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Mon Dec 06 22:04:22 CST 2021, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 20:31:33 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 欧洲专家共识：一线卵巢癌BRCA_同源重组缺陷检测.pdf)])
2021 欧洲专家共识：一线卵巢癌BRCA_同源重组缺陷检测.pdf
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1212196, encodeId=c6b412121960a, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd68122286, createdName=ms3000001251915184, createdTime=Mon Apr 18 15:23:21 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184161, encodeId=41a511841611c, content=谢谢分享，请多多分享哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1d76465788, createdName=msyx Carol0512, createdTime=Fri Jan 14 09:50:54 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083350, encodeId=a518108335079, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:55:00 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083349, encodeId=bea21083349c2, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:54:58 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077949, encodeId=942910e794907, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Dec 08 06:58:32 CST 2021, time=2021-12-08, status=1, ipAttribution=)]
    2022-04-18 ms3000001251915184

    学习学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1212196, encodeId=c6b412121960a, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd68122286, createdName=ms3000001251915184, createdTime=Mon Apr 18 15:23:21 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184161, encodeId=41a511841611c, content=谢谢分享，请多多分享哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1d76465788, createdName=msyx Carol0512, createdTime=Fri Jan 14 09:50:54 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083350, encodeId=a518108335079, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:55:00 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083349, encodeId=bea21083349c2, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:54:58 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077949, encodeId=942910e794907, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Dec 08 06:58:32 CST 2021, time=2021-12-08, status=1, ipAttribution=)]
    2022-01-14 msyx Carol0512

    谢谢分享，请多多分享哦

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1212196, encodeId=c6b412121960a, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd68122286, createdName=ms3000001251915184, createdTime=Mon Apr 18 15:23:21 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184161, encodeId=41a511841611c, content=谢谢分享，请多多分享哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1d76465788, createdName=msyx Carol0512, createdTime=Fri Jan 14 09:50:54 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083350, encodeId=a518108335079, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:55:00 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083349, encodeId=bea21083349c2, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:54:58 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077949, encodeId=942910e794907, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Dec 08 06:58:32 CST 2021, time=2021-12-08, status=1, ipAttribution=)]
    2021-12-22 一己怀

    谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1212196, encodeId=c6b412121960a, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd68122286, createdName=ms3000001251915184, createdTime=Mon Apr 18 15:23:21 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184161, encodeId=41a511841611c, content=谢谢分享，请多多分享哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1d76465788, createdName=msyx Carol0512, createdTime=Fri Jan 14 09:50:54 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083350, encodeId=a518108335079, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:55:00 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083349, encodeId=bea21083349c2, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:54:58 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077949, encodeId=942910e794907, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Dec 08 06:58:32 CST 2021, time=2021-12-08, status=1, ipAttribution=)]
    2021-12-22 一己怀

    谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1212196, encodeId=c6b412121960a, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd68122286, createdName=ms3000001251915184, createdTime=Mon Apr 18 15:23:21 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184161, encodeId=41a511841611c, content=谢谢分享，请多多分享哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1d76465788, createdName=msyx Carol0512, createdTime=Fri Jan 14 09:50:54 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083350, encodeId=a518108335079, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:55:00 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083349, encodeId=bea21083349c2, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:54:58 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077949, encodeId=942910e794907, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Dec 08 06:58:32 CST 2021, time=2021-12-08, status=1, ipAttribution=)]
    2021-12-08 微探

    学习学习

    0

相关指南

PARP抑制剂不良反应管理的中国专家共识

中国抗癌协会妇科肿瘤专业委员会 · 2021-11-01

上皮性卵巢癌PARP抑制剂相关生物标志物 检测的中国专家共识 2020

中国抗癌协会(Chinese Anti-cancer Association) · 2021-09-01

2021 ESGO指南：晚期卵巢癌减瘤手术的围术期管理

欧洲妇科肿瘤学会(ESGO,European Society of Gynecological Oncology) · 2021-08-18

晚期上皮性卵巢癌新辅助化疗指征的快速指南（2021年版）

中国医师协会微无创分会乳腺专家委员会 · 2021-04-20

SEOM卵巢癌临床指南 2020

西班牙医学肿瘤学会（ Spanish Society of Medical Oncology） · 2021-02-01

拓展阅读

同源重组修复缺陷临床检测与应用专家共识（2021版）

中国抗癌协会肿瘤标志专业委员会遗传性肿瘤标志物协作组 · 2021-08-25